Abstract. It is well known that an injection of prostaglandin F2α (PGF2α) or its analogue during the mid luteal phase of the estrous cycle induces a rapid decrease in plasma progesterone (P4) concentration, followed by luteolysis in the cow. There is evidence that a potent vasoactive peptide, endothelin-1 (ET-1), is produced in the bovine corpus luteum (CL), and that it is directly involved in luteolysis. We previously found that ET-1 concentrations in the peripheral plasma increase during the period of luteolysis and ovulation in cows. However, it is not clear whether the elevation of peripheral plasma ET-1 concentration observed during luteolysis and ovulation originates exclusively from the ovary and/or CL. Such a profile of plasma ET-1 concentration may be affected by the age of female calves as well as the activity of the ovary. Thus, we aimed to 1) determine in detail the changes in plasma ET-1 and P4 concentrations during the estrous cycle in the cow, 2) investigate plasma changes in ET-1 and P4 concentrations in new-born, 120-day-old and 240-day-old female calves, and 3) examine the effect of luteolytic injection of PGF2α analogue on the plasma ET-1 concentrations in the animals in this study. The peripheral plasma ET-1 concentrations in the cycling cows showed a pulsatile increase. They reached the their highest level (13.66 pg/ml) around the time of luteolysis and estrus, dropped significantly during Days 2-12 (early to mid luteal phase) and Days 13-19 (late luteal phase) (p<0.05), and then increased again on Days 20-22 (p<0.05) when the next estrus appeared. In the peripheral plasma of newborn, 120-day-old and 240-day-old female calves, P4 concentrations remained at low levels (0.1-0.2 ng/ml). ET-1 concentrations in these animals were lower than those in the cycling cows, and remained at low levels throughout the experimental period. Moreover, plasma ET-1 concentrations, unlike those in the cycling cow, did not change after a luteolytic PGF2α injection. In conclusion, the results of the present study gave the first detailed information that plasma ET-1 concentrations increase in a pulsatile manner after the onsets of spontaneous luteolysis and PGF2α-induced luteolysis in cycling cows, but not in female calves. The results suggest that the changes in the plasma ET-1 concentrations during the estrous cycle directly correlate with the cyclic changes in the ovarian function and the uterus.
luteum (CL) also decreases dramatically at this stage [1, 2] .
Endothelin-1 (ET-1), a potent vasoactive peptide consisting of 21 amino acids, was originally isolated from cultured endothelial cells [3] . It is also produced in the bovine CL, and its production increases 3-fold after the onset of luteolysis in comparison with that in the early to mid luteal phase [4] . In addition, the expression of the endothelin type A receptor (ET A -R) mRNA in bovine CL increases about 2.5-fold at luteolysis [5] . Furthermore, ET-1 has been shown to suppress P4 production in bovine luteal cell culture [6] . We have also shown that an infusion of ET-1 into an in vitro microdialysis system (MDS) implanted within the midcycle bovine CL suppresses P 4 release, and th a t thi s in hi bitin g ef f e ct wa s a ppa rentl y potentiated by preperfusion with PGF2α [7, 8] . We have further found that by using in vivo MDS surgically implanted into the midcycle CL, the ET-1 secretion after a luteolytic injection of PGF 2α rapidly increased within the regressing CL. This increase was accompanied by an increase in ET-1 concentrations in the ovarian venous plasma (OVP) ipsilateral to the CL and also in the jugular venous plasma (JVP) [9] . All of the above findings strongly suggest that ET-1 secretion in the CL correlates directly to luteolysis in the cow, which involves both P4 suppression and vasoconstriction.
Vascular endothelial cells are not only the structure of the blood container, but also they have the ability to produce and release ET-1 [10] . These cells are distributed in the whole body, and locally secreted ET-1 has numerous functions [11, 12] . Therefore, it was not clear whether the elevation of peripheral plasma ET-1 concentration observed during luteolysis and ovulation originates exclusively from the ovary and/or CL. Such a profile of plasma ET-1 concentration may be affected by the age of female calves as well as the activity of the ovary.
In this study, we aimed to 1) determine in detail the changes in plasma ET-1 and P4 concentrations during the estrous cycle in the cow; 2) investigate plasma changes in ET-1 and P 4 concentrations in new-born, 120-day-old and 240-day-old female calves; and 3) examine the effect of luteolytic injection of a PGF2α analogue on the plasma ET-1 concentrations in these animals. The obtained data indicated that the ovarian cycle, particularly luteolysis and estrus, was directly correlated with t h e i n c r e a s e i n p e r i p h e r a l p l a s m a E T -1 concentration. In contrast, the calves without an ovarian cycle showed no change in plasma ET-1 concentration.
Materials and Methods

Experimental design and animals
The first study was designed to determine P 4 and ET-1 concentrations in the peripheral plasma during the estrous cycle. Five multiparous lactating Holstein cows in the mid luteal phase were used for this purpose. They had at least 2 estrous cycles of normal length (21-22 days) before being used. Twelve hours after the first blood samples were collected, five hundred micrograms of the PGF2α analogue cloprostenol (Estrumate, Sumitomo Pharm. Co., Osaka, Japan) was injected intramuscularly on Days 10-12 to induce luteolysis. Three days after the PGF 2α injection, all five cows showed estrus. This was designated as Day 0. Blood samples were collected for the next 21-23 days until the following estrus and ovulation were confirmed. A 16-gauge catheter (Medicut Catheter Kit; Argyle Co., Japan Sherwood, Tokyo, Japan) was inserted into the jugular vein and sutured. Blood samples (10 ml) were collected from this catheter at 3-h intervals during Days -3.5 to 3, Days 8 to 11 and Days 17 to 23, and at 12-h intervals during other periods.
The second study used three groups of six calves, with ages of 1 day, 120 days, and 240 days. The start of the experiment was designated as Day 1. Blood samples (10 ml) were collected once a day (0600 h) from Day 1 to Day 20, and at 12-h intervals (0600 and 1800 h) from Day 21 to Day 26 from the jugular vein with disposable syringes. Five hundred micrograms of PGF 2 α analogue was intramuscularly injected at Day 22 immediately after the morning blood sampling.
The blood samples were collected in sterile glass tubes containing 200 µl of a stabilizer solution (0.3 M EDTA, 1% acid acetyl salicylic, pH 7.4) and were immediately chilled in ice water for 10 min and then centrifuged at 900 × g for 20 min at 4 C. The obtained plasma was stored at -30 C until further analysis.
Extraction for plasma P 4 T h e p l a s m a s a m p l e s ( 2 0 0 µ l ) f o r t h e P 4 determinations were extracted by diethyl ether as described previously [9] . The residue was dissolved in 200 µl of assay buffer (40 mM PBS, 0.1% BSA, pH 7.2). The recovery rate of plasma P 4 was previously found to be 85% in our laboratory.
Extraction of plasma ET-1
The plasma samples (3 ml) were diluted with 3 ml of distilled water, and the pH was adjusted to 2.5 with 5N HCl. The samples were then applied to a Sep-Pak C18 Cartridge (Waters, Millford, MA) as described previously [7] . The residue was evaporated and then dissolved in 200 µl of assay buffer (42 mM Na2HPO4, 8 mM KH2PO4, 20 mM NaCl, 4.8 mM EDTA, 0.05% BSA, pH 7.5) for the ET-1 enzyme immunoassay (EIA). The plasma samples were concentrated 15-fold as a result of this process and this enabled us to determine ET-1 concentration in the EIA within the range of the standard curve. The recovery rate of plasma ET-1 (50 pg/ml) that had been added to the plasma was 53%. All values of ET-1 concentration in the present study were corrected by the recovery rate.
Hormone determination
P4 and ET-1 concentrations were determined in the plasma with second-antibody EIAs that were based on a competitive assay using horseradish peroxidase-labeled P4 or biotin-labeled ET-1 as tracers.
Concentrations of P4 were assayed as described in detail previously [13] . The standard curve of P4 ranged from 0.05 to 50 ng/ml, and the ED 50 of the assay was 1.8 ng/ml. The intra-and interassay coefficients of variation (CVs) were on average 6.2% and 9.3%, respectively. The EIA for ET-1 was conducted as described previously [7] . The standard curve of ET-1 ranged from 9.7 to 5000 pg/ ml, and the ED 50 of the assay was 450 pg/ml. The intra-and interassay CVs of the ET-1 assay were on average 8.7% and 12.6%, respectively.
Statistical analysis
In order to analyze the changes in the plasma concentrations of P 4 and ET-1, the estrous cycle was divided into four periods (Days -2 to 1, Days 2 to 12, Days 13 to 19 and Days 20 to 22). The absolute concentrations of each hormone during these periods were averaged, and the mean values were compared with each other. The mean values were calculated using all the data from within the respective periods. Means were analyzed by ANOVA, followed by the Tukey-Kramer test as a multiple comparison test. To compare the plasma hormone concentrations in the female calves among Days 1 to 7, Days 8 to 14, Days 15 to 21.5, and after PGF 2α injection (Days 22.5 to 26), data points during these periods were averaged, and the mean values were compared with each other. Data are presented as means ± SEM. Means were analyzed by ANOVA, followed by the TukeyKramer test as a multiple comparison test.
Results
Changes in P4 and ET-1 concentrations in the peripheral plasma during the estrous cycle after PGF 2α injection in cycling cows are shown in Fig. 1 . Three days after the PGF2α injection, the five cycling cows showed estrus. This was designated as Day 0. Plasma P 4 concentrations showed a typical pattern during the estrous cycle. Namely, they decreased immediately after PGF2α injection, remained low until Day 2, gradually increased from Day 2 to Day 13, reached the highest level on Day 14 and decreased thereafter. The peripheral plasma ET-1 concentrations in the cycling cows showed a pulsatile increase (Fig. 2) . They reached the their highest level (13.66 pg/ml) around luteolysis and estrus, dropped to low levels during Days 2-12 (early to mid luteal phase) and Days 13-19 (late luteal phase) (p<0.05, Table 1 ) and then increased again on Days 20-22 (p<0.05, Table  1 ), when the next estrus appeared (Fig. 2) .
Changes in P4 and ET-1 concentrations in the peripheral plasma of the newborn, 120-day-old and 240-day old female calves during 26 days are shown in Fig. 3 . In all three groups of female calves, P 4 concentrations remained at low levels (0.1-0.2 ng/ml). ET-1 concentrations of these animals were lower than those of the cycling cows (Tables 1 and 2) , and remained at low levels throughout the experimental period. Moreover, plasma ET-1 concentrations, unlike those in the cycling cows, did not change after a luteolytic PGF2α injection.
Discussion
Th e re su lts of th e present s tudy clearly d e m o n s t r a t e d t h a t p e r i p h e r a l p l a s m a concentrations of ET-1 were highest around luteolysis and estrus in cycling cows. In addition, a luteolytic dose of PGF2α analogue rapidly increased plasma ET-1 concentration in the cycling cows during the mid luteal phase. However, the same luteolytic dose of PGF2α did not affect the plasma concentrations of ET-1 in the female calves lacking the ovarian cycle. Thus, this study confirmed our previous result on the changes in plasma ET-1 concentration during the estrous cycle [9] , and showed for the first time that plasma ET-1 increased in a pulsatile manner.
On the basis of detailed observations of the relationship between plasma ET-1 and P4 in each cow, the most active secretion of ET-1 appeared to correlate with estrus, rather than luteolysis. In this context, the bovine mature follicle has also been The active pulsatile release of ET-1 is obvious during both periestrous periods, whereas no pulsatile pattern is observed during the mid luteal phase.
shown to be the site of ET-1 secretion [14, 15] , in addition to CL [4, 6, 7, 9] . Interestingly, LH enhanced the ET-1 release from mature follicles in vitro [14] , and the ET-1 concentration in the ovarian venous plasma increased immediately after the LH surge in the cow [16] . Thus, the active secretion of Table 1 . Plasma concentrations of progesterone and endothelin during estrous cycle in the cow (n=5; Mean ± SEM). ET-1 during the periovulatory period may partly reflect increased ET-1 release from ovulatory follicles. Recently, it has been shown that the intrauterine infusion of an ETA-R antagonist on Days 16-18 of the estrous cycle prolonged the functional lifespan of the CL and the P4 concentration declined more slowly than it did in normal luteolysis [17] . These findings suggest that ET-1 of uterine origin takes part in the local control of uterine function via ET A -R during luteolysis in the cow, and the production and binding of ET-1 in the endometrial cells have been demonstrated in ewes [18, 19] . Considering the mass of the uterus and the CL, the major part of the increase in plasma ET-1 during luteolysis might be the result of increased ET-1 production in the uterus rather than in the CL.
Cycling cows
In support of this hypothesis, the plasma ET-1 levels observed in the calves (2-6 pg/ml) were well comparable with those in the cycling cows of the early to mid luteal phases (5-10 pg/ml), which were the lowest levels during the estrous cycle in the present study. These results imply that the increase of ET-1 secretion in the uterus after the onset of luteolysis may stimulate a local release of PGF2α toward the CL. As PGF2α is a clear stimulator of ET-1 from the CL [4, 6, 7, 9] , the increased ET-1 release together with oxytocin from the regressing CL might in turn accelerate the PGF2α release from the uterus. Clearly, this hypothesis needs further investigation. Although the present study revealed a clear pulsatile secretion of ET-1 in the peripheral plasma during luteolysis and periovulatory period in the cow, the mechanism underlying the cause of such pulsatility and its physiological relevance are unclear.
At all ages of female calves, the peripheral plasma ET-1 concentrations showed only basal secretion without any clear pulses. In other words, the age before sexual maturation did not relate to the change in plasma ET-1 concentration, even after PGF2α injection. The results suggest that the cyclic change in peripheral plasma ET-1 concentration depends on the active contraction of the uterus and the regression of functional CL.
In conclusion, the results of the present study gave the first detailed information that the plasma ET-1 concentrations increase in a pulsatile manner after the onsets of spontaneous luteolysis and PGF 2α -induced luteolysis in cycling cows, but not in female calves. These results suggest that the cyclic changes in plasma ET-1 concentrations during the estrous cycle directly correlate with the cyclic changes in the function of the ovary and the uterus.
